Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,728 across all filing types
Latest filing 2015-03-16 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
监事会关于使用部分闲置募集资金进行现金管理的审核意见
Audit Report / Information Classification · 90% confidence The document is a supervisory board's audit opinion on the use of part of idle raised funds for cash management. It references regulatory guidelines and company rules related to the management and use of raised funds. The content is an audit opinion rather than a full financial report or announcement of voting results. It does not contain financial statements or detailed financial data but is a formal audit-related statement. Therefore, it fits best under Audit Report / Information (AR). The document length is short but contains substantive audit opinion content, not just an announcement or certification. FY 2013
2015-03-16 Chinese
关于2014年年度股东大会增加临时提案的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the 2014 Annual General Meeting (AGM) of Kunming Pharmaceutical Group Co., Ltd. It details the type and date of the AGM, the shareholder who proposed the temporary proposal, the proposal content, and voting arrangements. The document does not contain the full AGM materials or presentations but rather announces changes related to the AGM agenda. The document length is short (1964 characters), and it serves as a notice about the AGM agenda change rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM agenda.
2015-03-16 Chinese
2015年日常关联交易预估补充公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's 2015 estimated daily related party transactions, including purchase and sales amounts, related parties involved, and the approval process by the board and independent directors. It includes financial figures but focuses on the forecast and disclosure of related party transactions rather than comprehensive financial statements or full financial performance. It is not an annual or interim report, audit report, earnings release, or other financial report type. The document is a regulatory announcement about related party transactions, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance disclosure.
2015-03-13 Chinese
独立董事关于昆明制药2015年度日常关联交易预估的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent director's opinion on the estimated daily related-party transactions for the year 2015 of Kunming Pharmaceutical Group Co., Ltd. It references regulatory guidelines for independent directors and discusses the nature and impact of these transactions. The document is short (360 characters) and focuses on an independent opinion rather than presenting full financial data or audit results. It does not contain comprehensive financial statements or detailed audit findings, so it is not an Annual Report (10-K) or Audit Report (AR). Instead, it is a standalone opinion related to governance and compliance with listing rules, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a regulatory compliance document.
2015-03-13 Chinese
关于为子公司昆明中药厂有限公司提供担保的补充公告
Regulatory Filings Classification · 95% confidence The document is a supplementary announcement correcting previous disclosures about guarantees provided by Kunming Pharmaceutical Group Co., Ltd. for its subsidiary. It includes details about the guarantee amounts and clarifications on previous figures. The document is short (913 characters) and serves as a correction or update to a prior announcement rather than a full financial report or detailed filing. It does not contain financial statements or comprehensive financial data. This type of document fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and corrections that do not fit other specific categories.
2015-03-13 Chinese
关于为子公司昆明制药集团医药商业有限公司提供担保的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding a previous guarantee announcement made by Kunming Pharmaceutical Group Co., Ltd. It corrects details about guarantees provided to a subsidiary, including amounts and percentages relative to audited net assets and total assets. The document is short (836 characters) and is an announcement correcting prior information rather than a full financial report or detailed filing. It does not contain financial statements or detailed financial analysis. It is a regulatory announcement correcting prior disclosures about guarantees, which fits best under Regulatory Filings (RNS).
2015-03-13 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.